You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (36)

Journals (0)

1-10 of 36 results for Aducanumab

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Making the Case for Accelerated Withdrawal of Aducanumab

Free access

Meeting report

First published 2022-05-31

Making the Case for Accelerated Withdrawal of Aducanumab

Peter Whitehouse, Sam Gandy, Vikas Saini [...]

Journal of Alzheimer’s Disease

Select article: Making the Case for the Accelerated Withdrawal of Aducanumab

Retricted access

Article commentary

First published 2022-05-31

Making the Case for the Accelerated Withdrawal of Aducanumab

Peter J. Whitehouse, Vikas Saini

Journal of Alzheimer’s Disease

Select article: Accelerated Approval of Aducanumab: Where Do We Stand Now?

Retricted access

Editorial

First published 2022-6

Accelerated Approval of Aducanumab: Where Do We Stand Now?

Hedva Barenholtz Levy

Annals of Pharmacotherapy

Select article: Under-Represented Populations Left Out of Alzheimer’s Disease Treatment with Aducanumab: Commentary on Ethics

Open access

Article commentary

First published 2022-06-22

Under-Represented Populations Left Out of Alzheimer’s Disease Treatment with Aducanumab: Commentary on Ethics

Sanjana P. Padala, Brandon C. Yarns

Journal of Alzheimer's Disease Reports

Select article: Aducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging Data

Retricted access

Article commentary

First published 2021-12-07

Aducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging Data

Poul F. Høilund-Carlsen, Abass Alavi

Journal of Alzheimer’s Disease

Select article: A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer’s Disease

Retricted access

Review article

First published 2021-10-12

A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer’s Disease

Sanchari Mukhopadhyay, Debanjan Banerjee

Journal of Alzheimer’s Disease

Select article: Effect of Aducanumab Approval on Willingness to Participate in Preclinical Alzheimer’s Disease Trials

Retricted access

Research article

First published 2022-11-22

Effect of Aducanumab Approval on Willingness to Participate in Preclinical Alzheimer’s Disease Trials

Marina Ritchie, Megan Witbracht, Michelle M. Nuño [...]

Journal of Alzheimer’s Disease

Select article: Reducing ARIA risk in Alzheimer's disease: Real-world impact of APOE genotype-guided slow titration with aducanumab and lecanemab

Retricted access

Research article

First published 2025-10

Reducing ARIA risk in Alzheimer's disease: Real-world impact of APOE genotype-guided slow titration with aducanumab and lecanemab

Nicholas Mervosh, Nadir Bilici, Thomas Wisniewski [...]

Journal of Alzheimer’s Disease

Select article: Comparative Efficacy,Tolerability,and Acceptability of Donanemab,Lecanemab,Aducanumab,Melatonin,and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer’s Disease: A Systematic Review and Network Meta-Analysis

Retricted access

Review article

First published 2024-04-02

Comparative Efficacy,Tolerability,and Acceptability of Donanemab,Lecanemab,Aducanumab,Melatonin,and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer’s Disease: A Systematic Review and Network Meta-Analysis

Itsuki Terao, Wakako Kodama

Journal of Alzheimer’s Disease

Select article: Comparative efficacy,tolerability,and acceptability of aducanumab,lecanemab,and donanemab with repetitive transcranial magnetic stimulation on cognitive function in mild cognitive impairment and Alzheimer’s disease: A systematic review and network meta-analysis

Retricted access

Review article

First published 2025-11

Comparative efficacy,tolerability,and acceptability of aducanumab,lecanemab,and donanemab with repetitive transcranial magnetic stimulation on cognitive function in mild cognitive impairment and Alzheimer’s disease: A systematic review and network meta-analysis

Itsuki Terao, Wakako Kodama

Journal of Psychopharmacology

1
2
3
4
10 / page

Article type

Publication date

Subjects

Access